PSMA PET–CT in initial prostate cancer staging
Crossref DOI link: https://doi.org/10.1038/nrurol.2016.136
Published Online: 2016-07-19
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Verburg, Frederik A.
Pfestroff, Andreas
Text and Data Mining valid from 2016-07-19
Article History
First Online: 19 July 2016
Competing interests
: F.A.V. is a consultant to Bayer Healthcare and Genzyme. A.P. declares no competing interests.